Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ocumension Therapeutics ( (HK:1477) ) has issued an announcement.
Ocumension Therapeutics has announced the composition of its board of directors, highlighting the roles and functions of its members. This structural update is poised to impact the company’s governance and strategic direction, potentially influencing its operations and positioning within the ophthalmology sector.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry with a primary emphasis on therapies and treatments related to ophthalmology.
YTD Price Performance: -17.33%
Average Trading Volume: 1,438,654
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.07B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.